Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a complex small molecule characterized by a 1,4-thiazane-3-carboxylic acid core, an L-Leucine moiety, and a p-toluenesulfonyl group. While specific pharmacological details for this exact molecule are not readily available, related benzothiazine derivatives have been noted for a wide range of biological and pharmacological properties, including anticancer, antioxidant, antimicrobial, antibacterial, antifungal, antiviral, antimalarial, antidiabetic, antihypertensive, anti-inflammatory, analgesic, anti-rheumatic, and anti-allergic activities. L-Leucine, a component of this compound, is an essential branched-chain amino acid crucial for protein synthesis and metabolic regulation. The p-toluenesulfonyl group is often used in organic synthesis as a protecting group or to introduce specific chemical properties. The precise mechanism of action or primary indication for this specific compound is not detailed in the provided search results, suggesting it may be a research chemical or an intermediate rather than a clinically developed drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine.